A real-world assessment of PIK3CA testing and alpelisib treatment patterns among metastatic breast cancer patients in a community oncology setting

被引：0
|
作者：
O'Shaughnessy, Joyce
Paulson, Steven
Brisbin, Lorraine
Lindsey, James
Williford, Anna
Lisi, Monica
Parikh, Rohan C.
Simmons, Stacey
Balu, Sanjeev
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS21-P5-13-16
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-13-16
引用
收藏
页数：3
相关论文
共 50 条
  • [31] First-line treatment patterns among patients with metastatic pancreatic ductal adenocarcinoma in the real-world setting
    Dennen, Syvart
    Harton, Joanna
    Cockrum, Paul
    Kim, George P.
    MacEwan, Joanna P.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [32] Real-world patterns of care among patients with metastatic pancreatic cancer (mPC)
    O'Reilly, Eileen Mary
    Surinach, Andy
    Wu, Zheng
    Cockrum, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [33] Real-World Evaluation of Treatment Patterns Among Patients With Chronic-Phase Chronic Myeloid Leukemia (CMLCP) in a Large Community Oncology Setting
    Zackon, Ira
    McDermott, Courtney
    Beeks, April
    Wentworth, Chuck
    Guo, Jinhong
    Jadhav, Kejal
    Wei, David
    Damon, Andrea
    Sadek, Islam
    Benton, Christopher
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S381 - S381
  • [34] Real-world treatment patterns of adult multiple myeloma patients treated with carfilzomib in the US community oncology setting.
    Panjabi, Sumeet
    Medhekar, Rohan
    Aguilar, Kathleen
    Wilson, Thomas
    Amirian, E. Susan
    Mezzi, Khalid
    Rifkin, Robert M.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [35] REAL-WORLD TREATMENT OF PATIENTS WITH TRK FUSION CANCER IN COMMUNITY ONCOLOGY PRACTICE
    Klink, A.
    Kavati, A.
    Gassama, A.
    Antoine, R.
    Kozlek, T.
    Gajra, A.
    VALUE IN HEALTH, 2022, 25 (01) : S32 - S32
  • [36] Real-world clinical outcomes and treatment patterns among metastatic breast cancer (MBC) patients with germline BRCA mutation (gBRCAmut).
    Quek, Ruben
    Mardekian, Jack
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [37] Real-World Patterns of Molecular Genetic Testing Among Patients with Acute Myeloid Leukemia in US Community Oncology Settings
    Lyons, Roger
    Sura, Sneha
    Annavarapu, Srinivas
    Kwong, Jackie
    Fliss, Albert
    BLOOD, 2021, 138
  • [38] Prevalence and prognosis of PIK3CA mutations in Bulgarian patients with metastatic breast cancer receiving endocrine therapy in first-line setting
    Gencheva, R.
    Petrova, M.
    Kraleva, P.
    Hadjidekova, S.
    Radanova, M.
    Conev, N.
    Stoyanov, D.
    Arabadjiev, J.
    Tazimova, E.
    Bachurska, S.
    Eneva, M.
    Tsvetkova, M.
    Zhbantov, G.
    Karanikolova, T.
    Manov, D.
    Ivanova, A.
    Taushanova-Hadjieva, M.
    Staneva, R.
    Dimitrova, E.
    Donev, I.
    CANCER REPORTS, 2024, 7 (02)
  • [39] Testing patterns and prevalence of PIK3CA, AKT1, and PTEN alterations among patients (pts) with HR+/HER2-metastatic breast cancer (mBC) in the US
    Park, Leah
    Thompson, Samantha L.
    Roose, James
    Lu, Yichen
    Chaki, Moumita
    Lam, Clara
    Iorgulescu, Bryan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [40] Correlation between circulating cell-free PIK3CA tumor DNA levels and treatment response in patients with PIK3CA-mutated metastatic breast cancer
    Kodahl, Annette R.
    Ehmsen, Sidse
    Pallisgaard, Niels
    Jylling, Anne M. B.
    Jensen, Jeanette D.
    Laenkholm, Anne-Vibeke
    Knoop, Ann S.
    Ditzel, Henrik J.
    MOLECULAR ONCOLOGY, 2018, 12 (06): : 925 - 935
12345